Clal Biotechnology Industries Ltd (CBI) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.033x

Based on the latest financial reports, Clal Biotechnology Industries Ltd (CBI) has a cash flow conversion efficiency ratio of -0.033x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million ≈ $-2.85K USD) by net assets (ILA32.60 Million ≈ $87.40K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Clal Biotechnology Industries Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Clal Biotechnology Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Clal Biotechnology Industries Ltd (CBI) total liabilities for a breakdown of total debt and financial obligations.

Clal Biotechnology Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clal Biotechnology Industries Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Argentina Lithium & Energy Corp V:LIT	-0.020x
Metro Bank PLC LSE:MTRO	0.026x
BTM Resources Bhd KLSE:7188	-0.033x
Jenn Feng New Energy Co Ltd TW:1538	-0.477x
Xref Ltd AU:XF1	0.137x
Energy Metals Ltd AU:EME	-0.004x
Fitzroy River Corporation Ltd AU:FZR	0.062x
RE Royalties Ltd V:RE	0.166x

Annual Cash Flow Conversion Efficiency for Clal Biotechnology Industries Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see CBI stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA46.16 Million ≈ $123.77K	ILA-6.48 Million ≈ $-17.37K	-0.140x	-100.12%
2023-12-31	ILA121.41 Million ≈ $325.49K	ILA-8.51 Million ≈ $-22.82K	-0.070x	+82.79%
2022-12-31	ILA144.90 Million ≈ $388.46K	ILA-59.04 Million ≈ $-158.28K	-0.407x	-233.60%
2021-12-31	ILA338.37 Million ≈ $907.16K	ILA-41.33 Million ≈ $-110.80K	-0.122x	-88.87%
2020-12-31	ILA513.79 Million ≈ $1.38 Million	ILA-33.23 Million ≈ $-89.08K	-0.065x	-219.11%
2019-12-31	ILA497.85 Million ≈ $1.33 Million	ILA27.03 Million ≈ $72.46K	0.054x	+154.16%
2018-12-31	ILA867.62 Million ≈ $2.33 Million	ILA-86.98 Million ≈ $-233.19K	-0.100x	+11.36%
2017-12-31	ILA808.20 Million ≈ $2.17 Million	ILA-91.41 Million ≈ $-245.05K	-0.113x	+24.44%
2016-12-31	ILA752.50 Million ≈ $2.02 Million	ILA-112.63 Million ≈ $-301.97K	-0.150x	-11.24%
2015-12-31	ILA1.09 Billion ≈ $2.93 Million	ILA-147.00 Million ≈ $-394.10K	-0.135x	-46.12%
2014-12-31	ILA1.26 Billion ≈ $3.38 Million	ILA-115.95 Million ≈ $-310.86K	-0.092x	+14.64%
2013-12-31	ILA1.38 Billion ≈ $3.70 Million	ILA-148.98 Million ≈ $-399.40K	-0.108x	-85.31%
2012-12-31	ILA1.40 Billion ≈ $3.74 Million	ILA-81.22 Million ≈ $-217.75K	-0.058x	+37.01%
2011-12-31	ILA1.11 Billion ≈ $2.97 Million	ILA-102.45 Million ≈ $-274.67K	-0.092x	-1.22%
2010-12-31	ILA1.23 Billion ≈ $3.29 Million	ILA-111.93 Million ≈ $-300.07K	-0.091x	+17.70%
2009-12-31	ILA782.91 Million ≈ $2.10 Million	ILA-86.86 Million ≈ $-232.87K	-0.111x	+41.91%
2008-12-31	ILA274.45 Million ≈ $735.80K	ILA-52.41 Million ≈ $-140.52K	-0.191x	-25.63%
2007-12-31	ILA309.49 Million ≈ $829.73K	ILA-47.05 Million ≈ $-126.14K	-0.152x	+24.93%
2006-12-31	ILA116.28 Million ≈ $311.75K	ILA-23.55 Million ≈ $-63.13K	-0.203x	--

About Clal Biotechnology Industries Ltd

TA:CBI Israel Biotechnology

Market Cap

$12.61 Million

ILA4.71 Billion ILA

Market Cap Rank

#26439 Global

#380 in Israel

Share Price

ILA30.00

Change (1 day)

+0.33%

52-Week Range

ILA27.30 - ILA42.50

All Time High

ILA380.64